Navigation Links
PathSensors receives expanded license from MIT for CANARY Technology
Date:7/10/2020

PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to include clinical applications for CANARY™ technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly sensitive assays will help to address the shortage of COVID-19 testing capabilities in the United States.

The company’s core business is environmental testing in fields such as building protection, mail security, food safety, and agriculture. Test panels for other infectious diseases will follow in future years.

“PathSensors originally developed CANARY™ technology for commercial use in 2012,” stated PathSensors’ President, Ted Olsen. “Now 8 years later, we are bringing CANARY™ to the healthcare field to provide rapid and highly sensitive detection solutions for a major public health crisis.”

About CANARY™
CANARY™ is a biosensor technology that delivers extremely rapid detection of pathogens with high sensitivity and specificity. Originally developed by scientists at MIT–Lincoln Laboratory to combat bioterrorism threats, CANARY™ has been licensed and commercialized by PathSensors, Inc.

About PathSensors, Inc.
PathSensors is a leading environmental testing company offering cutting-edge pathogen detection capabilities to a variety of industries including food safety, agriculture, infectious disease, and bioterrorism. The company makes the world a safer place by detecting pathogens that can cause sickness or worse while creating high technology jobs in the state of Maryland.

Read the full story at https://www.prweb.com/releases/pathsensors_receives_expanded_license_from_mit_for_canary_technology/prweb17246187.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. PathSensors Inc. Announced the Completion of Phase I of a SBIR
2. Roger Lawrence Appointed to PathSensors, Inc Scientific Advisory Board
3. PathSensors' Ralstonia and Phytophthora Assays Validated by the USDA
4. Bio-Tech Firm PathSensors Enters Fast-Growing Chinese Pathogen Detection Market
5. Bio-Tech Firm PathSensors Launches High-Throughput Diagnostics for Plant Safety at 2017 American Phytopathological Society (APS) Annual Conference
6. PathSensors Demonstrates Breakthrough Mail Security Screening Solution at National Postal Forum 2017
7. PathSensors Launches Low Cost, High Speed Anthrax and Bio Threat Detection Solution for Mail Security Screening
8. PathSensors to Develop and Commercialize Bio Sensor Technology to Combat Citrus Greening Disease (HLB)
9. Dr. Greg Lamka joins PathSensors Scientific Advisory Board
10. PathSensors Moves to the Columbus Center in Baltimores Inner Harbor
11. Vascular Medcure Receives Third FDA Clearance for CAPERE® Thrombectomy System – a Mechanical Device for Treatment of DVT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/12/2020)... ... August 12, 2020 , ... ... (EMMA International), a global leader in FDA compliance consulting has been named on ... private companies. The list represents a unique look at the most successful companies ...
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... 29, 2020 , ... Diversified Technologies, Inc. has introduced a ... to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... a push-pull configuration; yielding fast fall time for a capacitive load. These all ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted ... will cover the history of eSource, the reasons it did not take off as ... to site source, the industry is moving towards capturing data electronically for clinical trials ...
Breaking Biology Technology:
(Date:7/31/2020)... ... 30, 2020 , ... Justin Zamirowski to lead upcoming launches ... focus on Type 2 diabetes and associated comorbidities. , Justin brings over 20 ... classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ efforts ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage in ... COVID cure or vaccine, the global economic downturn will only increase price pressures overall ... away and capturing full value from every product launch is critical. However, history shows ...
(Date:7/4/2020)... ... 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics product ... only the products and treatments developed, but also the dedicated team behind the ... brands built by ABM have received several honors already for 2020, each of ...
Breaking Biology News(10 mins):